Brief: RVL Pharmaceuticals Posts Qtrly Loss Per Share Of $0.18
20/03/2023 11:42
March 20 (Reuters) - RVL Pharmaceuticals PLC RVLP.O :
* RVL PHARMACEUTICALS PLC- QTRLY LOSS PER SHARE $0.18
* RVL PHARMACEUTICALS PLC - AT DECEMBER 31, 2022, HAD CASH &
CASH
EQUIVALENTS OF $44.5 MILLION & LONG-TERM DEBT WITH AGGREGATE
AMOUNTS OF $75.0 MILLION
Source text for Eikon: ID:nGNX2Pt4bf
Further company coverage: RVLP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RVL Pharmaceuticals
See all newsBrief: RVL Pharmaceuticals Says High Court Of Ireland Made A Winding Up Order In Respect Of Co On Feb 12
Brief: RVL Pharmaceuticals Says Co Issued Petition In Central Office Of High Court In Ireland To Wind Up Company
Brief: RVL Completes Financial Restructuring
Brief: Rvl Pharmaceuticals PLC Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius